BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33292213)

  • 1. LncRNA SNHG3, a potential oncogene in human cancers.
    Xu B; Mei J; Ji W; Bian Z; Jiao J; Sun J; Shao J
    Cancer Cell Int; 2020 Nov; 20(1):536. PubMed ID: 33292213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small nucleolar RNA host gene 3 functions as a novel biomarker in liver cancer and other tumour progression.
    Shan DD; Zheng QX; Wang J; Chen Z
    World J Gastroenterol; 2022 Apr; 28(16):1641-1655. PubMed ID: 35581965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer.
    Ma Q; Qi X; Lin X; Li L; Chen L; Hu W
    Hum Cell; 2020 Jan; 33(1):232-242. PubMed ID: 31586299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma.
    Chen J; Wu Z; Zhang Y
    Int J Immunopathol Pharmacol; 2019; 33():2058738418820743. PubMed ID: 30791797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
    Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
    Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a Novel Cuproptosis-Related ceRNA Network-SNHG3/miR-1306-5p/PDHA1 and Identification of SNHG3 as a Prognostic Biomarker in Hepatocellular Carcinoma.
    Pan Y; Zhang Y; Hu X; Li S
    ACS Omega; 2023 Oct; 8(41):38690-38703. PubMed ID: 37867671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the Long Noncoding RNA SNHG3 Promotes Lung Adenocarcinoma Proliferation.
    Liu L; Ni J; He X
    Dis Markers; 2018; 2018():5736716. PubMed ID: 30154938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA SNHG3 acts as a novel Tumor Suppressor and regulates Tumor Proliferation and Metastasis via AKT/mTOR/ERK pathway in Papillary Thyroid Carcinoma.
    Duan Y; Wang Z; Xu L; Sun L; Song H; Yin H; He F
    J Cancer; 2020; 11(12):3492-3501. PubMed ID: 32284745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma.
    Zhang PF; Wang F; Wu J; Wu Y; Huang W; Liu D; Huang XY; Zhang XM; Ke AW
    J Cell Physiol; 2019 Mar; 234(3):2788-2794. PubMed ID: 30132868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer.
    Huang W; Tian Y; Dong S; Cha Y; Li J; Guo X; Yuan X
    Oncol Rep; 2017 Sep; 38(3):1402-1410. PubMed ID: 28731158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA-SNHG3 is an independent prognostic biomarker of intrahepatic cholangiocarcinoma.
    Tian D; Wei X; Zhu H; Zhu L; Li T; Li W
    Int J Clin Exp Pathol; 2019; 12(7):2706-2712. PubMed ID: 31934101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma.
    Zheng S; Jiang F; Ge D; Tang J; Chen H; Yang J; Yao Y; Yan J; Qiu J; Yin Z; Ni Y; Zhao L; Chen X; Li H; Yang L
    Biomed Pharmacother; 2019 Apr; 112():108695. PubMed ID: 30797154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA MEG3 play an important role in osteosarcoma development through sponging microRNAs.
    Jiang M; Wang YR; Xu N; Zhou L; An Q
    J Cell Biochem; 2019 Apr; 120(4):5151-5159. PubMed ID: 30324678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emerging Roles of LINC00665 in Human Cancers.
    Zhu J; Zhang Y; Chen X; Bian Y; Li J; Wang K
    Front Cell Dev Biol; 2022; 10():839177. PubMed ID: 35356290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
    Hong L; Chen W; Wu D; Wang Y
    Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative Analysis of Dysregulated lncRNA-Associated ceRNA Network Reveals Functional lncRNAs in Gastric Cancer.
    Liu H; Zhang Z; Wu N; Guo H; Zhang H; Fan D; Nie Y; Liu Y
    Genes (Basel); 2018 Jun; 9(6):. PubMed ID: 29912172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG3 regulates laryngeal carcinoma proliferation and migration by modulating the miR-384/WEE1 axis.
    Wang L; Su K; Wu H; Li J; Song D
    Life Sci; 2019 Sep; 232():116597. PubMed ID: 31238052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
    Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
    Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.